These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2191173)

  • 21. Increased total and regional vascular resistance produced by propranolol.
    Powell JR
    J Pharmacol Exp Ther; 1980 Apr; 213(1):64-9. PubMed ID: 7188965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiorespiratory effects of a 5HT2 antagonist (R51703) in awake and anesthetized dogs.
    Doherty TJ; McDonell WN; Dyson DH; Black WD
    Can J Vet Res; 1996 Jul; 60(3):172-8. PubMed ID: 8809379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog.
    Woodman OL; Vatner SF
    J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is adrenal medulla involved in the antihypertensive effect of nicardipine?
    Tran MA; De Saint-Blanquat G; Valet P; Tran LD; Anglade F; Gaillard G; Rascol O; Brisac AM; Montastruc JL; Montastruc P
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1116-20. PubMed ID: 3252026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of endothelin on the function of the isolated perfused working rat heart.
    Firth JD; Roberts AF; Raine AE
    Clin Sci (Lond); 1990 Sep; 79(3):221-6. PubMed ID: 2169369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pressor response to endothelin in guinea pigs.
    Li L; Ishikawa T; Miyauchi T; Yanagisawa M; Kimura S; Goto K; Masaki T
    Jpn J Pharmacol; 1989 Apr; 49(4):549-52. PubMed ID: 2657148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicardipine causes sympathetic activation that does not involve baroreceptor reflex tachycardia in conscious sinoaortic-denervated dogs.
    Damase-Michel C; Valet P; Montastruc JL
    Eur J Pharmacol; 1987 Oct; 142(1):145-9. PubMed ID: 3691633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of endothelin in dogs: positive inotropic action in vivo.
    Kitayoshi T; Watanabe T; Shimamoto N
    Eur J Pharmacol; 1989 Aug; 166(3):519-22. PubMed ID: 2680523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of endothelin on systemic and renal haemodynamics and neuroendocrine hormones in conscious dogs.
    Nakamoto H; Suzuki H; Murakami M; Kageyama Y; Ohishi A; Fukuda K; Hori S; Saruta T
    Clin Sci (Lond); 1989 Nov; 77(5):567-72. PubMed ID: 2555107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nicardipine hydrochloride on circulating blood volume and vascular compliance in dogs.
    Hashimoto S; Natsuyama T; Shigemi K; Chihara E; Kinoshita T; Tanaka Y; Miyazaki M
    Jpn Circ J; 1990 Feb; 54(2):146-51. PubMed ID: 2355450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mathematical model for dynamics of cardiovascular drug action: application to intravenous dihydropyridines in healthy volunteers.
    Francheteau P; Steimer JL; Merdjan H; Guerret M; Dubray C
    J Pharmacokinet Biopharm; 1993 Oct; 21(5):489-514. PubMed ID: 8145128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of nicardipine on the relationship of renal blood flow and of renal vascular resistance to perfusion pressure in dog kidney.
    Ogawa N
    J Pharm Pharmacol; 1990 Feb; 42(2):138-40. PubMed ID: 1972402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic actions of endothelin in conscious and anesthetized dogs.
    Given MB; Lowe RF; Lippton H; Hyman AL; Sander GE; Giles TD
    Peptides; 1989; 10(1):41-4. PubMed ID: 2664727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased plasma level of endothelin with vasoconstriction after dextran infusion.
    Otsuka A; Mikami H; Tsunetoshi T; Katahira K; Moriguchi A; Rakugi H; Suzuki N; Ogihara T
    Biochem Int; 1990 Oct; 22(2):353-9. PubMed ID: 1708666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic effect of endothelin, a novel potent vasoconstrictor in dogs.
    Otsuka A; Mikami H; Katahira K; Tsunetoshi T; Kohara K; Minamitani K; Moriguchi A; Ogihara T
    Clin Exp Pharmacol Physiol; 1990 May; 17(5):351-60. PubMed ID: 1972355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin-1 is a potent long-lasting vasoconstrictor in dog peripheral vasculature in vivo.
    Clarke JG; Larkin SW; Benjamin N; Keogh BE; Chester A; Davies GJ; Taylor KM; Maseri A
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S211-2. PubMed ID: 2473315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular actions of human endothelin in conscious sheep.
    Scoggins BA; Spence CD; Parkes DG; McDonald M; Wade JD; Coghlan JP
    Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):235-8. PubMed ID: 2663260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemodynamic effects of long-term endothelin infusion in conscious sheep.
    Reid AF; Parkes DG; Coghlan JP; Scoggins BA; Whitworth JA
    Clin Exp Pharmacol Physiol; 1990 Mar; 17(3):241-5. PubMed ID: 2187636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of endothelin-1 in vivo in humans.
    Haynes WG; Clarke JG; Cockcroft JR; Webb DJ
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S284-6. PubMed ID: 1725356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hemodynamic effects of endothelin-1 in the pithed rat.
    Walder CE; Thomas GR; Thiemermann C; Vane JR
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S93-7; discussion S102. PubMed ID: 2473337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.